Anna Schuh, MD, PhD, MRCP, FRCPath, from the University of Oxford, Oxford, UK, is an honorary Consultant Haematologist and Director of Molecular Diagnostics in the Department of Oncology. Her work is focused on chronic lymphocytic leukaemia (CLL) and molecular diagnostics, and she is the Director of the Oxford NHS/BRC Molecular Diagnostics Centre (MDC). Dr Schuh’s fascinating work includes evaluating the clinical use of next generation sequencing (NGS) technologies to improve response prediction for CLL and haematological malignancies. Her laboratory developed the first fully-certified NGS multi-gene panels for diagnostics in the NHS, as well as the first to publish longitudinal whole genome sequencing studies for CLL patients undergoing treatment. Dr Schuh is a Chief or Principle Investigator on numerous highly anticipated clinical trials for CLL, many of which are likely to have a significant impact on clinical practices. Furthermore, Dr Schuh has a research interest in the rare Richter’s Syndrome.
VJHemOnc is intended for Healthcare Professionals only
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest Hemonc news and updates
The content of VJHemOnc is intended for healthcare professionals